Episode #101|Therapeutic Hardware: Can Implants Also Heal? With Alyssa Huffman Allumin8

In this episode, Alyssa Huffman, CEO and co-founder of Allumin8, shares the six-year journey behind a first-of-its-kind 5.5 mm porous, 3D-printed pedicle screw. We discussed how Allumin8 earned FDA clearance and why design details matter for fatigue, fixation, and fewer revisions. We also map a path toward “therapeutic hardware” that integrates orthobiologics without slowing surgeons down. Join us as we explore the challenges, triumphs, and vision behind Allumin8’s mission to change lives.

⚠️ Disclaimer:
This podcast is for educational and informational purposes only. The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional.

Support The Show

Key Takeaways:

Why does a 5.5 mm screw matter?
How does Gaussian topography support bone ingrowth?
What are some of the lessons from fatigue testing and post-processing?
What are the additive vs milled manufacturing trade-offs?
What was Allumin8’s FDA journey and strategy?
When and how do orthobiologics add value?
How did Alyssa build a purpose-aligned team and investor base?
What are some practical founder advice on equity and boards?
What is on Alyssa’s wishlist for the future of orthopedic implants? 

“I saw catastrophic failures occur in the OR, but then I saw the ripple effects of what those catastrophic failures meant for patients.”

Scientific papers and technical resources

Regulatory and clinical

Orthobiologics and spine surgery background

For spinal fusion/pedicle screw revision as context:

Tools, books, and founder resources

Allumin8/Press

About Our Guest:

Alyssa Huffman

Alyssa Huffman is an award-winning MedTech entrepreneur, inventor, and thought leader focused on advancing orthopedic and spine care. Highly regarded in the industry, she was the first Commercial Representative appointed to the North American Spine Society (NASS) and is a respected voice in global spine innovation, championing evidence-based strategies at major conferences. Her initial inspiration came in 2009 while working as a distributor, when she witnessed the devastating complications of failed spine surgery on family members. This led to the first sketch of the A8 INTEGR8™ Porous Pedicle Screw System—the cornerstone of her company ALLUMIN8’s Therapeutic Hardware™ platform—which integrates biomechanical support with regenerative potential.

Under her leadership, ALLUMIN8 has achieved global recognition, including the “Best Technology in Spine” Award from Orthopedics This Week, the Global Impact Award 2025 from WashU in St. Louis, and significant funding from organizations like the Missouri Technology Corporation and St. Louis Arch Grants. Beyond her entrepreneurial endeavors, Huffman has contributed to clinical scholarship as a co-author on topics such as innovations in spine surgery and analgesic effects for trigeminal neuralgia. Her two decades of consulting experience span a wide range of MedTech areas, from medical devices to stem cell therapies. Her mission is to solve problems for patients, physicians, healthcare organizations, and payors by merging rigorous clinical evidence with cost-conscious innovation to accelerate the future of patient care.

Past interview podcasts

Comments